Phagos Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $29.3M

  • Investors
  • 24

Phagos General Information

Description

Operator of a biotechnology research company intended to provide customizable drugs to replace antibiotics in animal farming. The company uses a natural predator of bacteria that can constitute an efficient and sustainable alternative to antibiotics, enabling health professionals to overcome incurable and deadly infectious diseases.

Contact Information

Website
www.phagos.org
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 Rue Gardenat Lapostol
  • 92150 Suresnes
  • France
+33 06
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 5 Rue Gardenat Lapostol
  • 92150 Suresnes
  • France
+33 06

Phagos Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phagos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Early Stage VC (Series A) 08-Oct-2025 $29.3M Completed Generating Revenue
12. Early Stage VC 18-Nov-2024 Cancelled Generating Revenue
11. Accelerator/Incubator 21-Mar-2024 Completed Generating Revenue
10. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Accelerator/Incubator 01-Nov-2022 Completed Generating Revenue
7. Seed Round 15-Sep-2022 Completed Startup
6. Accelerator/Incubator 01-Jan-2022 Completed Stealth
5. Accelerator/Incubator 01-Jan-2022 Completed Stealth
4. Accelerator/Incubator 25-Oct-2021 Completed Stealth
To view Phagos’s complete valuation and funding history, request access »

Phagos Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
Ordinary Shares
A Shares 16,853 $0.117377 $553.85 $553.85 1x $553.85 15.59%
Seed-1 26,294 $0.117377 $81.51 $81.51 1x $81.51 24.33%
To view Phagos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Phagos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phagos Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
Acurio Ventures Partners Venture Capital Minority
Bpifrance Sovereign Wealth Fund Minority
Capagro Venture Capital Minority
CapHorn Invest Venture Capital Minority
Citizen Capital Impact Investing Minority
You’re viewing 5 of 24 investors. Get the full list »

Ready to get started?

Request a free trial

Phagos FAQs

  • When was Phagos founded?

    Phagos was founded in 2021.

  • Where is Phagos headquartered?

    Phagos is headquartered in Suresnes, France.

  • What is the size of Phagos?

    Phagos has 50 total employees.

  • What industry is Phagos in?

    Phagos’s primary industry is Drug Discovery.

  • Is Phagos a private or public company?

    Phagos is a Private company.

  • What is the current valuation of Phagos?

    The current valuation of Phagos is .

  • What is Phagos’s current revenue?

    The current revenue for Phagos is .

  • How much funding has Phagos raised over time?

    Phagos has raised $31.9M.

  • Who are Phagos’s investors?

    Acurio Ventures Partners, Bpifrance, Capagro, CapHorn Invest, and Citizen Capital are 5 of 24 investors who have invested in Phagos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process